- cafead Jan 24, 2025 at 11:52: AM
via Traws Pharma has completed the Phase I clinical trials of tivoxavir marboxil, a single-dose drug for treating or preventing H5N1 bird flu.
The randomised, placebo-controlled, double-blind trial evaluated the pharmacodynamics (PD), tolerability, pharmacokinetics (PK), and safety of escalating doses in healthy and influenza-negative adult volunteers.
article source
The randomised, placebo-controlled, double-blind trial evaluated the pharmacodynamics (PD), tolerability, pharmacokinetics (PK), and safety of escalating doses in healthy and influenza-negative adult volunteers.
article source